IRadimed

IRadimed EBIT Margin

The EBIT Margin (Operating Margin) of IRadimed (IRMD) as of Oct 10, 2026 is 31.20 %. In the previous year, EBIT Margin (Operating Margin) was 29.99 % — a change of 4.03% (higher).

EBIT Margin

31.20 %

YoY

4.03%

Last updated:

EBIT Margin (Operating Margin) of IRadimed is 2025 31.20 % . EBIT Margin (Operating Margin) of IRadimed was 2024 29.99 % . It decreases by 4.03% higher compared to the previous year.

IRadimed's operating (EBIT) margin stands at 31.2%, up from 23.5% several years earlier.

The IRadimed EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
19.72 USD
Jan 1, 2019
22.45 USD
Jan 1, 2020
-2.38 USD
Jan 1, 2021
23.48 USD
Jan 1, 2022
29.32 USD
Jan 1, 2023
30.56 USD
Jan 1, 2024
29.99 USD
Jan 1, 2025
31.20 USD
The IRadimed EBIT Margin history
YEAREBIT MarginYoY
31.20 %+4.03%
29.99 %-1.87%
30.56 %+4.23%
29.32 %+24.87%
23.48 %-1,084.93%
-2.38 %-110.62%
22.45 %+13.83%
19.72 %+254.29%
5.57 %-83.43%
33.60 %-7.79%
36.44 %+86.05%
19.59 %+7,868.97%
0.25 %+32.59%
0.19 %—
Access this data via the Eulerpool API

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IRadimed stock

EBIT Margin (Operating Margin) of IRadimed is 31.20 % in 2025.

EBIT Margin (Operating Margin) of IRadimed changed from 29.99 % to 31.20 %, representing a 4.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) IRadimed since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s IRadimed with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — IRadimed

All Key Metrics — IRadimed